Piloting the effective therapeutic dose of adjunctive selective estrogen receptor modulator treatment in postmenopausal women with schizophrenia

Summary Estrogen treatment may enhance the recovery of schizophrenia in women. However, adverse effects on uterine and breast tissue and other physical side effects may limit the long-term therapeutic use of estrogen. Raloxifene hydrochloride is a selective estrogen receptor modulator that acts as a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Psychoneuroendocrinology 2010-09, Vol.35 (8), p.1142-1147
Hauptverfasser:	Kulkarni, Jayashri, Gurvich, Caroline, Lee, Stuart J, Gilbert, Heather, Gavrilidis, Emmy, de Castella, Anthony, Berk, Michael, Dodd, Seetal, Fitzgerald, Paul B, Davis, Susan R
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult and adolescent clinical studies Behavioral psychophysiology Biological and medical sciences Dose-Response Relationship, Drug Double-Blind Method Drug Therapy, Combination Endocrinology & Metabolism Female Fundamental and applied biological sciences. Psychology Hormones and behavior Humans Medical sciences Middle Aged Pilot Projects Placebos Postmenopausal Postmenopause - drug effects Psychiatry Psychology. Psychoanalysis. Psychiatry Psychology. Psychophysiology Psychopathology. Psychiatry Psychoses Raloxifene hydrochloride Raloxifene Hydrochloride - administration & dosage Raloxifene Hydrochloride - adverse effects Raloxifene Hydrochloride - pharmacology Schizophrenia Schizophrenia - drug therapy Selective Estrogen Receptor Modulators - administration & dosage Selective Estrogen Receptor Modulators - adverse effects Selective Estrogen Receptor Modulators - pharmacology Treatment Outcome Women
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!